Options
Personalised and progressive neuromuscular electrical stimulation (NMES) in patients with cancera clinical case series
Date Issued
2019-10-01
Date Available
2019-06-10T13:49:54Z
Abstract
Purpose
Neuromuscular electrical stimulation (NMES) may be a pragmatic short-term alternative to voluntary exercise to augment cancer rehabilitation. However, previous attempts to use NMES as an exercise modality in this cohort have been unsuccessful, largely due to the use of NMES protocols that were developed for other rehabilitation contexts. We assessed the effects of a personalised and progressive NMES exercise intervention, designed with early stage cancer rehabilitation in mind, on exercise capacity, lower body functional strength and quality of life in (QoL) in patients who are currently undergoing or have recently completed treatment for cancer.
Methods
Ten adult patients were recruited. A personalised and progressive NMES exercise intervention was implemented in each case over a 4 – 8-week period. The 30 seconds sit to stand test (STS), 6-minute walk test (6MWT), and EORTC QLQ C-30 were performed pre-and post-intervention. Patients completed semi structured interviews post intervention to explore their experiences and views on the intervention, and its impact on their daily lives.
Results
Six of the 10 recruited patients completed the intervention and completed pre-and post assessments. Four of 6 patients improved STS, 5 of 6 patients improved 6MWT and 4 of 6 patients improved Global QoL. Perceived benefits included improved muscle strength and more confidence when walking.
Conclusion
A personalised and progressive NMES exercise intervention appears safe and may improve functional capacity and QoL in adults who are undergoing or have recently completed treatment for cancer. Replication of these results in a controlled prospective study is warranted prior to clinical implementation.
Neuromuscular electrical stimulation (NMES) may be a pragmatic short-term alternative to voluntary exercise to augment cancer rehabilitation. However, previous attempts to use NMES as an exercise modality in this cohort have been unsuccessful, largely due to the use of NMES protocols that were developed for other rehabilitation contexts. We assessed the effects of a personalised and progressive NMES exercise intervention, designed with early stage cancer rehabilitation in mind, on exercise capacity, lower body functional strength and quality of life in (QoL) in patients who are currently undergoing or have recently completed treatment for cancer.
Methods
Ten adult patients were recruited. A personalised and progressive NMES exercise intervention was implemented in each case over a 4 – 8-week period. The 30 seconds sit to stand test (STS), 6-minute walk test (6MWT), and EORTC QLQ C-30 were performed pre-and post-intervention. Patients completed semi structured interviews post intervention to explore their experiences and views on the intervention, and its impact on their daily lives.
Results
Six of the 10 recruited patients completed the intervention and completed pre-and post assessments. Four of 6 patients improved STS, 5 of 6 patients improved 6MWT and 4 of 6 patients improved Global QoL. Perceived benefits included improved muscle strength and more confidence when walking.
Conclusion
A personalised and progressive NMES exercise intervention appears safe and may improve functional capacity and QoL in adults who are undergoing or have recently completed treatment for cancer. Replication of these results in a controlled prospective study is warranted prior to clinical implementation.
Sponsorship
European Commission Horizon 2020
Other Sponsorship
Insight Research Centre
Type of Material
Journal Article
Publisher
Springer
Journal
Supportive Care in Cancer
Volume
27
Issue
10
Start Page
3823
End Page
3831
Copyright (Published Version)
2019 Springer
Language
English
Status of Item
Peer reviewed
This item is made available under a Creative Commons License
File(s)
No Thumbnail Available
Name
insight_publication.pdf
Size
549.14 KB
Format
Adobe PDF
Checksum (MD5)
9851f1f55c79d1cb51084db32a02e12d
Owning collection
Mapped collections